Kyverna Therapeutics, Inc. - Common Stock (NQ:KYTX)

2.175 -0.145 (-6.26%)

Streaming Delayed Price Updated: 3:44 PM EDT, May 14, 2025 Add to My Watchlist

Price and Volume

Volume	243,529
Open	2.320
Bid (Size)	2.170 (5)
Ask (Size)	2.180 (5)
Prev. Close	2.320
Today's Range	2.060 - 2.369
52wk Range	1.780 - 17.55
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR) - Grabar Law Office Is Investigating Claims on Your

April 17, 2025

From Grabar Law Office

Via GlobeNewswire

ALERT: Grabar Law Office Investigates Claims for Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); and Virtu Financial, Inc. (NASDAQ: VIRT)

March 31, 2025

From Grabar Law Office

Via GlobeNewswire

Performance

YTD	-44.5%	-44.5%
1 Month	-2.5%	-2.5%
3 Month	-25.8%	-25.8%
6 Month	-58.3%	-58.3%
1 Year	-85.1%	-85.1%

More News

Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is

March 24, 2025

From Grabar Law Office

Via GlobeNewswire

Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your

March 21, 2025

From Grabar Law Office

Via GlobeNewswire

Notice to Long-Term Shareholders of Archer-Daniels-Midland Co. (NYSE: ADM); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Kyverna Therapeutics, Inc. (Nasdaq: KYTX); and Mercury Systems, Inc. (Nasdaq: MRCY): Grabar Law Office is Investigating Claims on Your

March 18, 2025

From Grabar Law Office

Via GlobeNewswire

Top movers in Monday's after hours session

March 17, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session

March 17, 2025

Via Benzinga

Notice to Long-Term Shareholders of Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Is Investigating Claims on Your Behalf

March 17, 2025

From Grabar Law Office

Via GlobeNewswire

Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf

March 13, 2025

From Grabar Law Office

Via GlobeNewswire

Deadline Soon: Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

February 05, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

KYTX Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit

February 04, 2025

Via NewMediaWire

KYTX Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit

February 04, 2025

Via TheNewswire.com

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics

February 04, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kyverna, Sun Communities, DMC Global, and Marqeta and Encourages Investors to Contact the Firm

February 03, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

KYVERNA THERAPEUTICS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX

February 03, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

KYTX Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit

February 03, 2025

Via NewMediaWire

KYTX Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit

February 03, 2025

Via TheNewswire.com

KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline

February 03, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

KYTX Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit

February 02, 2025

Via NewMediaWire

KYTX Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit

February 02, 2025

Via TheNewswire.com

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics

February 02, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

KYTX Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit

February 01, 2025

Via NewMediaWire

KYTX Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit

February 01, 2025

Via TheNewswire.com

Important February 7, 2025 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Investors of Securities Fraud Class Action Lawsuit

January 30, 2025

Via NewMediaWire

Important February 7, 2025 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Investors of Securities Fraud Class Action Lawsuit

January 30, 2025

Via TheNewswire.com

Frequently Asked Questions

Is Kyverna Therapeutics, Inc. - Common Stock publicly traded?

Yes, Kyverna Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Kyverna Therapeutics, Inc. - Common Stock trade on?

Kyverna Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Kyverna Therapeutics, Inc. - Common Stock?

The ticker symbol for Kyverna Therapeutics, Inc. - Common Stock is KYTX on the Nasdaq Stock Market

What is the current price of Kyverna Therapeutics, Inc. - Common Stock?

The current price of Kyverna Therapeutics, Inc. - Common Stock is 2.175

When was Kyverna Therapeutics, Inc. - Common Stock last traded?

The last trade of Kyverna Therapeutics, Inc. - Common Stock was at 05/14/25 03:44 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.